PAS Kinase Assay Using Phosphorylation Site-Specific Antibodies
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to accurately measure intracellular PAS kinase activity, which is crucial for developing effective therapies for metabolic syndromes and related conditions, due to the complex spatiotemporal and environmental sensitivity of PASK regulation in vivo.
Innovation Solution
Development of robust and reliable assays that measure PAS kinase activity by determining its phosphorylation level or ability to phosphorylate a novel substrate protein, allowing for high-throughput screening of compounds, including the use of phosphorylation site-specific antibodies and yeast Ugp1 as a substrate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods are used to measure PAS kinase activity, then the measurement process is simple, but the measurement precision is insufficient due to complex spatiotemporal and environmental sensitivity of PASK regulation
Solution Approach 1:
The patent uses an intermediary substrate (GST-fused PASK substrate or yeast Ugp1 protein) that specifically interacts with PAS kinase to enable accurate measurement. This intermediary translates the complex kinase activity into a measurable phosphorylation event, resolving the contradiction between measurement precision and assay complexity by providing a dedicated molecular mediator that simplifies the detection process while maintaining accuracy
Solution Approach 2:
The patent employs parameter changes by measuring phosphorylation levels at specific sites (Ser-116, Thr-1161, Thr-1165) as quantitative indicators of PAS kinase activity. By converting the complex regulatory state into discrete phosphorylation parameter measurements, the assay achieves high precision without requiring complex instrumentation, thus resolving the technical contradiction
2Reliability
If robust and reliable assays are developed to measure PAS kinase activity, then the reliability is improved, but the ease of operation decreases due to multiple measurement steps
Solution Approach 1:
The patent segments the assay into distinct modules: (1) substrate preparation (GST-fused substrate or yeast Ugp1 expression), (2) kinase reaction incubation, and (3) phosphorylation detection (Western blot or ELISA). This segmentation allows each module to be optimized independently for reliability while maintaining overall operational simplicity through standardized protocols, resolving the contradiction between reliability and ease of operation
Solution Approach 2:
The assay utilizes self-service mechanisms where the PAS kinase substrate or yeast Ugp1 protein serves as both the target and the detection indicator. The phosphorylation event automatically generates a detectable signal without requiring additional labeling steps, thereby improving reliability while maintaining ease of operation through self-indicating assay design
3Measurement precision
If phosphorylation site-specific antibodies are used to detect PAS kinase activity, then the measurement precision is improved, but the manufacturing precision of antibodies is more difficult to achieve
Solution Approach 1:
The patent employs phosphorylation-specific antibodies that recognize conserved phospho-epitopes across multiple PAS kinase substrates. These universal antibodies can detect phosphorylation at key regulatory sites (Ser-116, Thr-1161, Thr-1165) regardless of the specific substrate context, thereby achieving high measurement precision while reducing the manufacturing complexity by using a single antibody reagent for multiple applications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These assays provide a simple and reliable means to detect PAS kinase activity within cells, enabling the identification of modulators and inhibitors, thereby facilitating the development of therapeutic treatments for metabolic syndromes.
Implementation Method 1
Protein kinases represent a large class of enzymes that function in the catalysis of phosphoryl transfer, mediating the transfer of a phosphate group from ATP to a protein substrate
Implementation Method 2
Protein kinase catalyzed phosphorylation events can act as molecular switches to modulate or regulate the biological function, or spatiotemporal position of the target protein
Data Source
AI summary
The present invention is directed towards methods for measuring and assaying PAS Kinase activity. The methods are useful, for example, for detecting PASK activity in a cell, and for screening for small molecule regulators of PAS kinase activity, as well as characterizing endogenous factors and stimuli that modulate PAS kinase activity, and identifying and optimizing the activity of potential PAS kinase inhibitors.